PUBLISHER: The Business Research Company | PRODUCT CODE: 1939215
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939215
An amnion patch is a medical product made from the amniotic membrane and is commonly used in surgery and wound care. It utilizes the membrane's natural anti-inflammatory and regenerative properties to support healing and tissue repair. The patch is placed over wounds or surgical areas to aid recovery, minimize scarring, and encourage tissue regeneration.
The major product types of amnion patches are transplantation-grade amnion patches, transplantation-grade amnion or chorion patches, and suspension liquid amnio patches. Transplantation-grade amnion patches are high-quality amniotic membrane products specially prepared for use in transplant-related medical procedures. Their applications include corneal repair, ocular surface reconstruction, amniotic membrane transplantation, dental procedures, wound healing, and orthopedic uses, and they are utilized by end-users such as hospitals, eye banks, clinics, and research institutions.
Tariffs are impacting the amnion patch market by increasing the cost of imported amniotic membrane products and preservation equipment. Segments such as cryopreserved and lyophilized transplantation-grade patches are particularly impacted, with regions like Asia-Pacific and North America facing higher import duties. This has led to increased product costs and supply chain adjustments. On the positive side, tariffs have encouraged local production, investment in domestic tissue banks, and innovation in preservation and packaging technologies.
The amnion patch market research report is one of a series of new reports from The Business Research Company that provides amnion patch market statistics, including amnion patch industry global market size, regional shares, competitors with a amnion patch market share, detailed amnion patch market segments, market trends and opportunities, and any further data you may need to thrive in the amnion patch industry. This amnion patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The amnion patch market size has grown strongly in recent years. It will grow from $1.91 billion in 2025 to $2.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to limited availability of amniotic membrane products, reliance on fresh tissue grafts, growing demand for ocular surface reconstruction, increasing hospital and clinic procedures, lack of standardized preservation techniques.
The amnion patch market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to development of cryopreserved and lyophilized amnion patches, rising adoption in corneal repair and ocular surgeries, growth in dental and orthopedic applications, increasing research and development initiatives, expansion of eye banks and tissue banks. Major trends in the forecast period include rising use of amnion patches in wound healing and tissue regeneration, increased adoption of cryopreserved and lyophilized products, expansion of ophthalmic and dental applications, growing focus on minimally invasive surgical procedures, enhanced regulatory compliance and quality standards for amniotic products.
The increasing prevalence of diabetes is expected to drive the growth of the amnion patch market going forward. The rise in diabetes prevalence is attributed to factors such as sedentary lifestyles, unhealthy dietary patterns, increasing obesity levels, aging populations, and genetic susceptibility. Amnion patches are used to treat diabetic foot ulcers caused by severe diabetes by promoting faster wound healing through the provision of bioactive tissue that supports cell regeneration and reduces inflammation. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that more than half a billion people worldwide were living with diabetes. This figure is projected to more than double, reaching 1.3 billion individuals by 2050. Therefore, the increasing prevalence of diabetes is driving the growth of the amnion patch market.
Companies operating in the amnion patch market are concentrating on developing innovative products, such as dehydrated dual-layer amniotic membrane patches, to deliver shelf-stable, biologically active scaffolds that support wound healing and protect tissue. A dehydrated dual-layer amniotic membrane patch is a two-layer allograft derived from placental tissue, processed to preserve extracellular matrix components while functioning as both a barrier and scaffold and remaining stable at room temperature. For example, in 2025, Mindsight Medical / Total Ancillary, a US-based provider of biologic wound care grafts, launched the RevoShield+ Dual Layer Amnio Patch. The patch is manufactured from dehydrated human amniotic membrane, offers a five-year shelf life at room temperature, and can be applied with or without glue or sutures. It reduces moisture loss, acts as a protective barrier, and supports tissue reconstruction in acute and chronic wounds, podiatry, Mohs surgery, and related applications.
In September 2023, Globus Medical, Inc., a US-based medical device company, merged with NuVasive to create a leading global organization advancing spine and orthopedic care through comprehensive procedural solutions and technologies. This merger brings together their complementary global scale, expanded commercial reach, extensive product portfolios, and shared commitment to product innovation, surgeon education, and improved operational capabilities. NuVasive Inc. is a US-based medical device company.
Major companies operating in the amnion patch market are Integra LifeSciences Corporation, AlloSource, Bio-Tissue Inc., Infinity Biologics Inc., VIVEX Biologics Inc., Tissue Regenix Ltd, Celularity, Royal Biologics, NuVision Biotherapies Ltd, Olifant Biologics, MTF Biologics, BioHealing, MiMedx Group Inc, Amnio Technology LLC, Amniox Medical Inc, Regenative Labs LLC, Organogenesis Inc, Skye Biologics Holdings LLC, Human Regenerative Technologies LLC, Genesis Biologics, Ventris Medical LLC
North America was the largest region in the amnion patch market in 2025. The regions covered in the amnion patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the amnion patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The amnion patch market consists of sales of amniotic fluid injections, amnion patch dressings, and amniotic membrane grafts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Amnion Patch Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses amnion patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for amnion patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The amnion patch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.